Dynavax Technologies Corporation
Drug Manufacturers - Specialty & Generic
Healthcare
DVAX
125 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.68
52 week high
14.40
high
9.84
52 week low
0.00
low
9.57
growth
-15.51 %
previous Close
9.69
P/E ratio
market cap
1.34 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
-100.00 %
net profit margin
0.00 %
140.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top